SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through ...

New research reveals the potential of drugs that have been on the market for decades to treat diseases other than those for ...

The U.S., Trump said, would no longer pay more than "the Nation that pays the lowest price anywhere in the World." ...

The difference between the best tablets and the worst can be stark. Our tough independent tests weed out the models to avoid and our expert buying advice will help you choose a winner. Use the results ...

Dupixent (dupilumab) Interleukin-4 receptor alpha antagonist Treatment of patients aged 12 years and older with chronic spontaneous urticaria who remain symptomatic despite H1 antihistamine treatment.

US President Trump signed an executive order on May 5 to rebuild US prescription drug manufacturing, with a focus on reducing reliance on foreign-made medicines, directing to accelerate facilities ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

ROCHESTER, N.Y. (WROC) — Four people have been arrested in Rochester following a multi-agency investigation into a Rochester drug trafficking organization. According to the Rochester Police Department ...

Just two years ago, the US was suffering through the worst stretch of its long-running drug overdose crisis. More than 110,000 Americans had died in the previous 12 months from an overdose ...

Announced Wednesday, the acquisition will hand the Swiss pharmaceutical firm a drug prospect called farabursen, which recently completed a Phase 1b study in people with autosomal dominant polycystic ...

The Food and Drug Administration on Wednesday approved an antibody drug that developer Johnson & Johnson expects will eventually become one of its top-selling medicines. The drug, which J&J will sell ...